Evidence map›Paper›PMID 32473594›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition.

Rami Hamati, Mostafa El Mansari, Pierre Blier

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. The Complex Role of Serotonin-Dopamine-Glutamate Receptors in Major Depression.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  7. Structure activity relationships of 5-HTEuropean journal of medicinal chemistry · 2023
    Article
  8. The Roles of Serotonin in Neuropsychiatric Disorders.Cellular and molecular neurobiology · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rami HamatiDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. rami.hamati@theroyal.ca.ORCID http://orcid.org/0000-0001-7213-9253
Mostafa El MansariMood Disorders Research Unit, University of Ottawa Institute of Mental Health Research, Ottawa, ON, Canada.
Pierre BlierDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous research has implicated the serotonin-2B (5-HT

Indexed as

DopamineSerotoninAnimalsGlutamic AcidRatsRats, Sprague-DawleyReceptor, Serotonin, 5-HT2BSelective Serotonin Reuptake InhibitorsDopamineGlutamic AcidReceptor, Serotonin, 5-HT2BSelective Serotonin Reuptake InhibitorsSerotonin

Identifiers

PMID32473594
PMCPMC7547697
OpenAlexW3030425123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.